Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients

Keyphrases

• Peripheral Blood 100%
• Malignant Cells 100%
• Bone Marrow 100%
• Circulating Tumor Cells 100%
• Multiple Myeloma Patients 100%
• Peripheral Blood Lymphocytes 100%
• Multiple Myeloma 66%
• Myeloma 66%
• Polymerase Chain Reaction 66%
• Complementarity-determining Region 3 (CDR3) 66%
• Allele-specific Oligonucleotides 66%
• Tumor 33%
• Disease Stage 33%
• Disease Burden 33%
• Tumor Burden 33%
• Bone Marrow Transplantation 33%
• Plasma Cells 33%
• Immunoglobulin Heavy Chain 33%
• Marrow 33%
• DNA Samples 33%
• Circulating Tumor DNA (ctDNA) 33%
• Titration 33%
• Previously Untreated 33%
• Tumor Stage 33%
• Oligonucleotide Primers 33%
• Peripheral Stem Cells 33%
• Amplification Reaction 33%
• Derived Allele 33%
• Alternative Assessment 33%

Immunology and Microbiology

• Multiple Myeloma 100%
• Allele 60%
• Peripheral Blood Lymphocyte 60%
• Circulating Tumor Cell 40%
• Polymerase Chain Reaction 40%
• Bone Marrow Transplantation 20%
• Tumor Volume 20%
• Stem Cell 20%
• Immunoglobulin Heavy Chain 20%
• Cancer Staging 20%
• Immunoglobulin Producing Cell 20%

Neuroscience

• Lymphocyte 100%
• Allele-Specific Oligonucleotide 66%
• Polymerase Chain Reaction 66%
• Stem Cell 33%
• Immunoglobulin Heavy Chain 33%
• Immunoglobulin Producing Cell 33%
• Oligonucleotide 33%